Wall Street Experts
ver. ZuMIgo(08/25)
Solid Biosciences Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 5
EBIT TTM (mln): -107
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
Rok finansowy |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
14 |
8 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
inf% |
-40.6% |
-100.0% |
0.0% |
Marża brutto |
0.0% |
0.0% |
-inf% |
0.0% |
-inf% |
-inf% |
100.0% |
70.2% |
-inf% |
0.0% |
EBIT (mln) |
-7 |
-26 |
-55 |
-76 |
-119 |
-88 |
-72 |
-106 |
-104 |
-130 |
EBIT Δ r/r |
0.0% |
289.6% |
114.5% |
38.0% |
57.6% |
-25.9% |
-18.3% |
47.3% |
-2.0% |
24.4% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-530.5% |
-1315.2% |
0.0% |
0.0% |
Koszty finansowe (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-20 |
0 |
-0 |
EBITDA (mln) |
-7 |
-26 |
-54 |
-76 |
-116 |
-81 |
-69 |
-108 |
-102 |
-130 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-508.7% |
-1333.4% |
0.0% |
0.0% |
Podatek (mln) |
-0 |
-3 |
-1 |
1 |
-2 |
2 |
-0 |
-20 |
0 |
0 |
Zysk Netto (mln) |
-6 |
-22 |
-52 |
-75 |
-116 |
-90 |
-72 |
-66 |
-96 |
-125 |
Zysk netto Δ r/r |
0.0% |
237.8% |
142.0% |
43.5% |
54.6% |
-22.1% |
-20.0% |
-9.2% |
46.6% |
29.9% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-529.5% |
-809.4% |
0.0% |
0.0% |
EPS |
-4.97 |
-16.8 |
-24.26 |
-33.73 |
-43.05 |
-26.03 |
-10.13 |
-7.7 |
-4.83 |
-3.06 |
EPS (rozwodnione) |
-4.97 |
-16.8 |
-24.26 |
-33.73 |
-43.05 |
-26.03 |
-10.13 |
-7.7 |
-4.83 |
-3.06 |
Ilośc akcji (mln) |
1 |
1 |
2 |
2 |
3 |
3 |
7 |
9 |
20 |
41 |
Ważona ilośc akcji (mln) |
1 |
1 |
2 |
2 |
3 |
3 |
7 |
9 |
20 |
41 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |